We are live on ! Find out more
CH

CVI Holdings Portfolio holdings

AUM $116M
1-Year Est. Return 5.68%
This Fund
S&P 500
This Quarter Est. Return
-10.59%
1 Year Est. Return
+5.68%
3 Year Est. Return
+25.77%
5 Year Est. Return
+327.29%
10 Year Est. Return
–
AUM
$44.5M
AUM Growth
-$42.1M
Cap. Flow
-$53.2M
Cap. Flow %
-119.42%
Top 10 Hldgs %
85.41%
Holding
81
New
17
Increased
1
Reduced
6
Closed
38

Top Buys

Rank Stock Value
1
OCGN icon
Ocugen
OCGN
+$4.57M
2
XCUR icon
Exicure
XCUR
+$3.25M
3
TPTX
Turning Point Therapeutics, Inc. Common Stock
TPTX
+$3M
4
TEUM
Pareteum Corporation
TEUM
+$2.51M
5
CRMD icon
CorMedix
CRMD
+$1.93M

Top Sells

Rank Stock Value
1
SCOR icon
Comscore
SCOR
+$14.1M
2
MDCO
Medicines Co
MDCO
+$4.12M
3
CARM
Carisma Therapeutics
CARM
+$3.95M
4
SRNE
Sorrento Therapeutics, Inc.
SRNE
+$3.74M
5
CALA
Calithera Biosciences, Inc
CALA
+$3.29M

Sector Composition

Rank Sector Weight
1 Healthcare 39.19%
2 Technology 6.18%
3 Communication Services 3.83%
4 Consumer Discretionary 1.4%
5 Materials 0.98%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CHEKZ
26
DELISTED
Check-Cap Ltd. Series C Warrant
CHEKZ
$27K 0.06%
136,364
– –
PHIO icon
27
Phio Pharmaceuticals
PHIO
$11.4M
$26K 0.06%
16
-52
-76% -$109K
FPAYW
28
DELISTED
FlexShopper, Inc. Warrants
FPAYW
$24K 0.05%
50,000
– –
SHIPW
29
DELISTED
Seanergy Maritime Holdings Corp Class A Warrants
SHIPW
$12K 0.03%
1,180,400
– –
MDGSW
30
DELISTED
Medigus Ltd. Series C Warrant
MDGSW
$6K 0.01%
63,286
-1,000
-2% -$482
CREXW
31
DELISTED
Creative Realities, Inc. Warrant
CREXW
$4K 0.01%
15,000
– –
ONTXW
32
DELISTED
Onconova Therapeutics, Inc. Warrants
ONTXW
$3K 0.01%
132,227
– –
AMRHW
33
DELISTED
Ameri Holdings, Inc. Warrant
AMRHW
$3K 0.01%
99,500
– –
SNGXW
34
DELISTED
Soligenix, Inc. Warrant
SNGXW
$2K ﹤0.01%
16,599
– –
PSTVZ
35
DELISTED
PLUS THERAPEUTICS, Inc. Series S Warrant
PSTVZ
$2K ﹤0.01%
+259,200
New +$3.14K
BNTCW
36
DELISTED
Benitec Biopharma Limited
BNTCW
$1K ﹤0.01%
50,000
– –
AQB icon
37
AquaBounty Technologies
AQB
$4.73M
– –
-17,260
Closed -$1.06M
ARTL icon
38
Artelo Biosciences
ARTL
$2.52M
– –
-152
Closed -$189K
BBGI icon
39
Beasley Broadcasting Group
BBGI
$35.3M
– –
-4,911
Closed -$316K
CLRB icon
40
Cellectar Biosciences
CLRB
$19.8M
– –
-353
Closed -$231K
CODX
41
Co-Diagnostics
CODX
$5.56M
– –
-3,644
Closed -$90K
CYCN icon
42
Cyclerion Therapeutics
CYCN
$15.2M
– –
-3,928
Closed -$899K
CHRN
43
ChronoScale Holdings
CHRN
$2.69B
– –
-1,727
Closed -$494K
EYPT icon
44
EyePoint Inc
EYPT
$999M
– –
-45,581
Closed -$748K
FURY
45
Fury Gold Mines
FURY
$101M
– –
-11,482
Closed -$29K
GNFT
46
DELISTED
Genfit
GNFT
– –
-138,185
Closed -$2.73M
INSM icon
47
Insmed
INSM
$22.4B
– –
-14,627
Closed -$374K
IZEA icon
48
IZEA Worldwide
IZEA
$58.7M
– –
-91,847
Closed -$188K
KURA icon
49
Kura Oncology
KURA
$793M
– –
-60,800
Closed -$1.2M
LAUR icon
50
Laureate Education
LAUR
$5.38B
– –
-121,792
Closed -$1.91M
1
2
3 4

Similar funds

EL
EMFO LLC Weston, Florida $112M AUM 18.79% 1-Year Est. Return
YSP
Yarra Square Partners New York $111M AUM 41.61% 1-Year Est. Return
GIM
Greenwich Investment Management Norwalk, Connecticut $109M AUM 9.72% 1-Year Est. Return
FWM
FMFE Wealth Management Syracuse, New York $108M AUM
CPG
Custom Portfolio Group Englewood, Colorado $127M AUM
WCM
Windham Capital Management Boston, Massachusetts $128M AUM 12.44% 1-Year Est. Return
ETIA
Epic Trust Investment Advisors Richland, Washington $90.8M AUM 22.03% 1-Year Est. Return
RCM
Rain Capital Management Lake Oswego, Oregon $142M AUM 15.53% 1-Year Est. Return

CVI Holdings's Q3 2019 Portfolio in Review

As of Q3 2019, CVI Holdings held 81 positions worth $44.5M, down 49% from $86.6M the previous quarter. Its ten largest holdings account for 85% of the portfolio.

CVI Holdings withdrew a net $53.2M in Q3 2019, closing 38 positions and reducing 6 holdings. Its most notable exit was Comscore, an estimated $14.1M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 39% of assets, up from 33% a quarter earlier, followed by Technology and Communication Services.

Against the trend, CVI Holdings opened a new position in Ocugen worth $1.06M.

  • CVI Holdings's largest Q3 2019 buy was Ocugen: 368,315 shares worth $1.06M.
  • CVI Holdings added most to Senmiao Technology Ltd in Q3 2019, an estimated $5.4K increase.
  • CVI Holdings's biggest Q3 2019 reduction was Carisma Therapeutics, cutting an estimated $3.95M.
  • CVI Holdings fully exited Comscore in Q3 2019, selling an estimated $14.1M.
  • CVI Holdings's ten largest holdings make up 85% of its $44.5M portfolio in Q3 2019.
  • CVI Holdings opened 17 new positions and closed 38 in Q3 2019.
  • CVI Holdings's portfolio value fell 49% quarter-over-quarter to $44.5M.

Based on CVI Holdings's 13F filing for Q3 2019, filed 14 Nov 2019.